Histologic distribution of borderline ovarian tumors worldwide: a systematic review

Song, Taejong; Lee, Yoo-Young; Choi, Chel Hun; Kim, Tae-Joong; Lee, Jeong‐Won; Bae, Duk-Soo; Kim, Byoung-Gie

doi:10.3802/jgo.2013.24.1.44

Cited by 42 publications

(28 citation statements)

References 51 publications

Supporting

Mentioning

Contrasting

Unclassified

Order By: Relevance

“…Asian women have a high incidence of BOTs, with varying histopathologic subtypes, especially mucinous BOTs [25] . The authors found that all 5 parameters showed better accuracy for BOTs that were classified as non-cancers.…”

Section: Discussionmentioning

confidence: 99%

Is the Risk of Ovarian Malignancy Algorithm Better Than Other Tests for Predicting Ovarian Malignancy in Women with Pelvic Masses?

Yanaranop¹,

Anakrat²,

Siricharoenthai³

et al. 2016

Gynecol Obstet Invest

View full text Add to dashboard Cite

Aim: The study aimed to compare the risk of ovarian malignancy algorithm (ROMA) with risk of malignancy index (RMI), cancer antigen 125 (CA125), human epididymis protein 4 (HE4) and Sassone ultrasonography (US) score in predicting ovarian cancer (OC) in women who present with pelvic or adnexal masses. Methods: Pelvic US, serum CA125 and HE4 levels were investigated preoperatively in consecutively enrolled Thai women over 18 years with clinically diagnosed pelvic or adnexal masses who were undergoing elective surgery at a super tertiary hospital in Thailand in 2012. ROMA, RMI and Sassone US score were calculated. Results: Of 260 women who were evaluated, 74 had OC. Areas under the receiver operating characteristic curve (AUC) in predicting OC were ROMA, 86.2%; RMI, 87.6%; CA125, 80.6%; HE4, 82.4%; and Sassone score, 77.1%. ROMA and RMI performed similarly well (AUCs 84.4 and 85.6%) in premenopausal women but RMI outperformed ROMA in postmenopausal women (AUCs 87.9 and 84.0%, respectively). At the conventional cutoff value, ROMA and CA125 showed the highest sensitivity (83.8%) but HE4 had the highest specificity (86.0%). Conclusions: ROMA was comparable to RMI in predicting OC. Either ROMA or RMI can be applied to women with pelvic masses, stratified into low- and high-risk groups for OCs.

show abstract

Section: Discussionmentioning

confidence: 99%

Is the Risk of Ovarian Malignancy Algorithm Better Than Other Tests for Predicting Ovarian Malignancy in Women with Pelvic Masses?

Yanaranop¹,

Anakrat²,

Siricharoenthai³

et al. 2016

Gynecol Obstet Invest

View full text Add to dashboard Cite

show abstract

“…Studies in the USA [31], France [32] and Italy [33] have reported serous-type BOTs as the most common (60-74%), while studies in Korea [34] and Japan [35] have reported mucinous-type BOTs as the most common (68-76%). According to a recent systematic review, in general, serous-type BOTs were the predominately identified histology in North America, the Middle East, and Europe, while mucinous-type BOTs predominated in East Asia [36]. …”

Section: Discussionmentioning

confidence: 99%

Endocervical-Like versus Intestinal-Type Mucinous Borderline Ovarian Tumors: A Large Retrospective Series Focusing on the Clinicopathologic Characteristics

Song

Choi²,

Lee³

et al. 2013

Gynecol Obstet Invest

Self Cite

View full text Add to dashboard Cite

Background/Aims: To evaluate the clinical and pathologic features of patients with mucinous borderline tumor (MBT) of the ovary with special emphasis on the endocervical-like (EMBT) and intestinal-type (IMBT). Methods: This is a retrospective review of patients with MBT who were diagnosed and treated between 1995 and 2009 at a single institution. The records were analyzed for the patients' clinicopathologic information. The survival rates were calculated using the Kaplan-Meier method. Results: Of a total of 203 patients with MBT, there were 56 (27.6%) with EMBTs and 147 (72.4%) with IMBTs. Patients with EMBTs were significantly more asymptomatic (58.9%), had higher CA125 and CA19-9 levels, larger tumors (mean 17.3 cm), less frequent bilateral occurrence (5.4%), and less relation to endometriosis (1.4%), compared with those with IMBTs (all p < 0.05). During the median follow-up of 57.3 months (range 6-158), a total of 8 recurrences were identified: 6 were borderline and 2 were invasive lesion. With regard to the recurrence, EMBT and IMBT showed a 7-year recurrence-free survival rate of 97.1 and 92.1%, respectively, with no significant difference. Conclusion: EMBT and IMBT had different clinicopathological profiles, although the histologic distinction of MBT was not associated with the prognosis.

show abstract

“…Interestingly, the incidence of M-BOT is reported to be higher in nonwhite patients comparable to invasive ovarian cancer. 10 Serous BOTs are confined to 1 ovary in 75% of cases. Extraovarian distribution is more frequent in S-BOT (25%) represented by peritoneal implants (21.7% any implants, 3.6% invasive implants).…”

Section: Pathologymentioning

confidence: 99%

Gynecologic Cancer InterGroup (GCIG) Consensus Review for Ovarian Tumors of Low Malignant Potential (Borderline Ovarian Tumors)

Harter

Gershenson

Lhommé

et al. 2014

Int J Gynecol Cancer

View full text Add to dashboard Cite

show abstract

Histologic distribution of borderline ovarian tumors worldwide: a systematic review

Cited by 42 publications

References 51 publications

Is the Risk of Ovarian Malignancy Algorithm Better Than Other Tests for Predicting Ovarian Malignancy in Women with Pelvic Masses?

Is the Risk of Ovarian Malignancy Algorithm Better Than Other Tests for Predicting Ovarian Malignancy in Women with Pelvic Masses?

Endocervical-Like versus Intestinal-Type Mucinous Borderline Ovarian Tumors: A Large Retrospective Series Focusing on the Clinicopathologic Characteristics

Gynecologic Cancer InterGroup (GCIG) Consensus Review for Ovarian Tumors of Low Malignant Potential (Borderline Ovarian Tumors)

Contact Info

Product

Resources

About